Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 68

1.

Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target.

Schjetne KW, Thompson KM, Nilsen N, Flo TH, Fleckenstein B, Iversen JG, Espevik T, Bogen B.

J Immunol. 2003 Jul 1;171(1):32-6.

2.

Toll-like receptor signaling pathways.

Barton GM, Medzhitov R.

Science. 2003 Jun 6;300(5625):1524-5.

PMID:
12791976
3.

CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells.

Liu N, Ohnishi N, Ni L, Akira S, Bacon KB.

Nat Immunol. 2003 Jul;4(7):687-93. Epub 2003 May 25.

PMID:
12766768
4.

Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events.

Boekholdt SM, Agema WR, Peters RJ, Zwinderman AH, van der Wall EE, Reitsma PH, Kastelein JJ, Jukema JW; REgression GRowth Evaluation Statin Study Group..

Circulation. 2003 May 20;107(19):2416-21. Epub 2003 May 12.

5.

Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.

Rui L, Vinuesa CG, Blasioli J, Goodnow CC.

Nat Immunol. 2003 Jun;4(6):594-600. Epub 2003 May 11.

PMID:
12740574
6.

Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span.

Sabroe I, Prince LR, Jones EC, Horsburgh MJ, Foster SJ, Vogel SN, Dower SK, Whyte MK.

J Immunol. 2003 May 15;170(10):5268-75.

8.

Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility.

Smirnova I, Mann N, Dols A, Derkx HH, Hibberd ML, Levin M, Beutler B.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):6075-80. Epub 2003 May 2.

9.

Dendritic cells: controllers of the immune system and a new promise for immunotherapy.

Banchereau J, Paczesny S, Blanco P, Bennett L, Pascual V, Fay J, Palucka AK.

Ann N Y Acad Sci. 2003 Apr;987:180-7. Review.

PMID:
12727638
10.

Dendritic cell function in vivo during the steady state: a role in peripheral tolerance.

Steinman RM, Hawiger D, Liu K, Bonifaz L, Bonnyay D, Mahnke K, Iyoda T, Ravetch J, Dhodapkar M, Inaba K, Nussenzweig M.

Ann N Y Acad Sci. 2003 Apr;987:15-25. Review.

PMID:
12727620
11.

Activation and regulation of Toll-like receptors 2 and 1 in human leprosy.

Krutzik SR, Ochoa MT, Sieling PA, Uematsu S, Ng YW, Legaspi A, Liu PT, Cole ST, Godowski PJ, Maeda Y, Sarno EN, Norgard MV, Brennan PJ, Akira S, Rea TH, Modlin RL.

Nat Med. 2003 May;9(5):525-32. Epub 2003 Apr 14.

PMID:
12692544
12.

The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.

Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A.

Blood. 2003 Aug 1;102(3):956-63. Epub 2003 Apr 10.

13.

A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.

Datta SK, Redecke V, Prilliman KR, Takabayashi K, Corr M, Tallant T, DiDonato J, Dziarski R, Akira S, Schoenberger SP, Raz E.

J Immunol. 2003 Apr 15;170(8):4102-10.

14.

Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.

Varadaradjalou S, F├ęger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M, Arock M.

Eur J Immunol. 2003 Apr;33(4):899-906.

15.

Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium.

Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T, Michel BA, Seger RA, Gay S, Lauener RP.

Am J Pathol. 2003 Apr;162(4):1221-7.

17.

Toll-like receptors and their role in experimental models of microbial infection.

Qureshi S, Medzhitov R.

Genes Immun. 2003 Mar;4(2):87-94. Review.

PMID:
12618855
18.
19.

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Pasare C, Medzhitov R.

Science. 2003 Feb 14;299(5609):1033-6. Epub 2003 Jan 16.

20.

Recognition of pathogen-associated molecular patterns by TLR family.

Akira S, Hemmi H.

Immunol Lett. 2003 Jan 22;85(2):85-95. Review.

PMID:
12527213

Supplemental Content

Support Center